1-14 of 14
Keywords: Placebo
Close
Sort by
Journal Articles
Journal Articles
Neuropsychobiology (1994) 30 (1): 37–41.
Published Online: 26 February 2008
...-medication titration was 3- to 4-fold more broad-ranging than i.m. medication titration, (b) oral placebo was titrated to the same extent as the oral investiga-tional drugs, and (c) the titration schedule did not follow protocol requirements. Moreover, the average doses in all drug and placebo groups were...
Journal Articles
Neuropsychobiology (1988) 20 (2): 78–81.
Published Online: 20 February 2008
... was administered double-blindly to 10 patients suffering from major depression resistant to previous treatments with tricyclics. The comparison group (10 patients) received placebo. Lorazepam (10 mg/day) was also given to both groups. Viqualine proved to be significantly superior to placebo in the 4th week...
Journal Articles
Neuropsychobiology (1988) 20 (2): 74–77.
Published Online: 20 February 2008
...E. Scarpini; P.G. Baron; L. Bet; G. Bottini; N. Bresolin; G. Meola; G. Pezzoli; G. Vallar; G.C. Monza; G. Scarlato A multicenter, double-blind, between-patient trial comparing two doses of ketazolam (15 and 30 mg) with placebo, each given once daily, in the evening, to 92 outpatients affected...
Journal Articles
Neuropsychobiology (1987) 18 (4): 189–194.
Published Online: 20 February 2008
...Aitor Castillo; Cesar Sotillo; Javier Mariategui In this double-blind study we compared alprazolam, clobazam, and placebo for the treatment of outpatients suffering from generalized anxiety disorder. At the end of the treatment, the three groups were significantly improved without showing...
Journal Articles
Journal Articles
Journal Articles
Neuropsychobiology (1985) 14 (3): 128–132.
Published Online: 19 February 2008
...Patrick J. McGrath; Judith G. Rabkin; Jonathan W. Stewart; Wilma Harrison; Frederic M. Quitkin; Jeffrey Markowitz Ninety-two outpatients with depressive disorders which met Research Diagnostic Criteria were treated either with mianserin or placebo in a 6-week controlled trial. Twenty-four of 42 (57...
Journal Articles
Neuropsychobiology (1983) 9 (1): 20–25.
Published Online: 19 February 2008
...J.D. Guelfi; P. Boyer; J.-F. Dreyfus The use of placebos is often justified in therapeutic drug testing. They may be employed in order to compare their effects with those of a so-called active treatment, to compare two active medications, in double-blind comparisons of two drugs of different...
Journal Articles
Neuropsychobiology (1984) 12 (2-3): 130–133.
Published Online: 19 February 2008
...M. Viukari; T. Vartio; E. Verho 0.125 mg brotizolam and 2.5 mg nitrazepam proved to be equipotent in promoting and maintaining sleep in 29 elderly patients used to long-term hypnotics. These drugs were superior to placebo and they were excellently tolerated. The drugs were administered in a random...
Journal Articles
Neuropsychobiology (1984) 12 (2-3): 134–137.
Published Online: 19 February 2008
...Matti Viukari; Pirkko Miettinen Diazepam 5 mg, promethazine 25 mg, propiomazine 25 mg, and placebo as sleeping aids were studied in 40 elderly inpatients. The drugs were administered in a random order, double-blind, on 21 nights. All active drugs were found effective in the mentally normal elderly...
Journal Articles
Neuropsychobiology (1983) 10 (2-3): 173–177.
Published Online: 19 February 2008
...Peter Irwin; Max Fink The need for a familiarization session and for a placebo session for each subject in pharmaco-EEG studies was examined. The data from 18 crossover studies of 22 substances at 33 doses in 112 subjects was used: 371 drug sessions, 195 placebo sessions and 53 familiarization...
Journal Articles
Neuropsychobiology (1976) 2 (5-6): 283–290.
Published Online: 14 February 2008
...W.G. Sannita; P. Irwin; M. Fink Effects of the heptapeptide ACTH 4–10 (Org OI-63) on EEG, some memory tests, and behavior were examined in 12 normal male volunteers under 30 years of age. An intravenous dose of 60 mg was compared to placebo in a Latin square design. EEG was recorded for 2 h after...
Journal Articles
Neuropsychobiology (1999) 39 (1): 25–32.
Published Online: 18 January 1999
...P. Boyer; Y. Lecrubier; A. Stalla-Bourdillon; O. Fleurot Amisulpride, a selective antagonist for D 2 and D 3 dopamine receptors, acts preferentially on presynaptic receptors increasing dopaminergic transmission at low doses. In a multicentre, 3-month, placebo-controlled study, amisulpride (50 mg...